We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
-15.38%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$605M
AUM Growth
-$43.1M
Cap. Flow
+$70M
Cap. Flow %
11.58%
Top 10 Hldgs %
48.94%
Holding
2,904
New
349
Increased
1,175
Reduced
755
Closed
206

Sector Composition

Rank Sector Weight
1 Financials 18.89%
2 Technology 11.62%
3 Healthcare 5.08%
4 Consumer Discretionary 3.93%
5 Energy 3.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRTN
1876
DELISTED
Triton International Limited
TRTN
$3K ﹤0.01%
66
+10
+18% +$605
PDCE
1877
DELISTED
PDC Energy, Inc.
PDCE
$3K ﹤0.01%
52
+15
+41% +$1.09K
UMPQ
1878
DELISTED
Umpqua Holdings Corp
UMPQ
$3K ﹤0.01%
205
+59
+40% +$1.02K
TEN
1879
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$3K ﹤0.01%
197
+157
+393% +$2.65K
CCXI
1880
DELISTED
ChemoCentryx, Inc.
CCXI
$3K ﹤0.01%
127
+69
+119% +$1.52K
POLY
1881
DELISTED
Plantronics, Inc.
POLY
$3K ﹤0.01%
76
CNR
1882
DELISTED
Cornerstone Building Brands, Inc.
CNR
$3K ﹤0.01%
119
-86
-42% -$2.1K
SBNY
1883
DELISTED
Signature Bank
SBNY
$3K ﹤0.01%
18
-11
-38% -$2.46K
AAP icon
1884
Advance Auto Parts
AAP
$3.49B
$2K ﹤0.01%
10
-11
-52% -$2.18K
AAT
1885
American Assets Trust
AAT
$1.4B
$2K ﹤0.01%
54
-91
-63% -$3.05K
ABCB icon
1886
Ameris Bancorp
ABCB
$5.89B
$2K ﹤0.01%
40
ABUS icon
1887
Arbutus Biopharma
ABUS
$915M
$2K ﹤0.01%
+565
New +$1.45K
ACAD icon
1888
Acadia Pharmaceuticals
ACAD
$5.03B
$2K ﹤0.01%
130
-37
-22% -$691
ADT icon
1889
ADT
ADT
$5.58B
$2K ﹤0.01%
245
AGEN
1890
Agenus
AGEN
$290M
$2K ﹤0.01%
50
-15
-23% -$545
AGIO icon
1891
Agios Pharmaceuticals
AGIO
$1.93B
$2K ﹤0.01%
74
+63
+573% +$1.42K
AHCO icon
1892
AdaptHealth
AHCO
$759M
$2K ﹤0.01%
+125
New +$2.03K
AIV
1893
Aimco
AIV
$383M
$2K ﹤0.01%
269
+54
+25% +$341
AKR icon
1894
Acadia Realty Trust
AKR
$2.84B
$2K ﹤0.01%
129
+97
+303% +$1.87K
ALEC icon
1895
Alector
ALEC
$199M
$2K ﹤0.01%
+183
New +$1.82K
ALV icon
1896
Autoliv
ALV
$9B
$2K ﹤0.01%
26
-9
-26% -$673
ALXO icon
1897
ALX Oncology
ALXO
$290M
$2K ﹤0.01%
215
+81
+60% +$882
AMRX icon
1898
Amneal Pharmaceuticals
AMRX
$5.79B
$2K ﹤0.01%
703
+539
+329% +$1.95K
ANAB icon
1899
AnaptysBio
ANAB
$1.68B
$2K ﹤0.01%
87
+45
+107% +$997
APPN icon
1900
Appian
APPN
$2.48B
$2K ﹤0.01%
52
+11
+27% +$553

Similar funds

Lindbrook Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Lindbrook Capital held 2,904 positions worth $605M, down 6.6% from $648M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Lindbrook Capital deployed $70M of net new capital in Q2 2022, opening 349 new positions and adding to 1,175 existing holdings. Its largest new stake was BlackRock MuniHoldings California Quality Fund: 50,522 shares worth $605K.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Digital Turbine, an estimated $3.57M trimmed.

  • Lindbrook Capital's largest Q2 2022 buy was BlackRock MuniHoldings California Quality Fund: 50,522 shares worth $605K.
  • Lindbrook Capital added most to Golub Capital BDC in Q2 2022, an estimated $26.1M increase.
  • Lindbrook Capital's biggest Q2 2022 reduction was Digital Turbine, cutting an estimated $3.57M.
  • Lindbrook Capital fully exited Berkshire Hathaway Class A in Q2 2022, selling an estimated $1.06M.
  • Lindbrook Capital's ten largest holdings make up 49% of its $605M portfolio in Q2 2022.
  • Lindbrook Capital opened 349 new positions and closed 206 in Q2 2022.
  • Lindbrook Capital's portfolio value fell 6.6% quarter-over-quarter to $605M.

Based on Lindbrook Capital's 13F filing for Q2 2022, filed 1 Aug 2022.